ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,193,000 | -0.1% | 902,500 | -5.0% | 0.05% | -13.1% |
| Q2 2020 | $2,195,000 | -19.9% | 950,000 | -5.0% | 0.06% | -47.4% |
| Q1 2020 | $2,740,000 | +132.2% | 1,000,000 | 0.0% | 0.12% | +152.2% |
| Q4 2019 | $1,180,000 | +11.3% | 1,000,000 | 0.0% | 0.05% | +9.5% |
| Q3 2019 | $1,060,000 | -31.2% | 1,000,000 | 0.0% | 0.04% | -32.3% |
| Q2 2019 | $1,540,000 | -61.3% | 1,000,000 | 0.0% | 0.06% | -62.0% |
| Q1 2019 | $3,980,000 | +50.8% | 1,000,000 | 0.0% | 0.16% | +66.3% |
| Q4 2018 | $2,640,000 | -34.7% | 1,000,000 | +81.8% | 0.10% | -6.7% |
| Q3 2018 | $4,043,000 | +5.0% | 550,000 | 0.0% | 0.10% | +28.0% |
| Q2 2018 | $3,850,000 | -24.7% | 550,000 | 0.0% | 0.08% | +28.1% |
| Q1 2018 | $5,115,000 | +241.0% | 550,000 | +175.0% | 0.06% | +178.3% |
| Q4 2017 | $1,500,000 | -29.6% | 200,000 | 0.0% | 0.02% | -37.8% |
| Q3 2017 | $2,130,000 | +86.8% | 200,000 | +100.0% | 0.04% | +85.0% |
| Q2 2017 | $1,140,000 | +6.0% | 100,000 | 0.0% | 0.02% | -16.7% |
| Q1 2017 | $1,075,000 | -5.7% | 100,000 | 0.0% | 0.02% | -4.0% |
| Q4 2016 | $1,140,000 | -8.3% | 100,000 | 0.0% | 0.02% | 0.0% |
| Q3 2016 | $1,243,000 | – | 100,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
| BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
| Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
| CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
| Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
| Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
| Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
| Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |